Terms: = Head and neck cancer AND MED12, Q93074, TRAP230, TNRC11, OKS, KIAA0192, HOPA, FGS1, CAGH45, ARC240, 9968
17 results:
1. Co-Culture of
Yáñez L; Soto C; Tapia H; Pacheco M; Tapia J; Osses G; Salinas D; Rojas-Celis V; Hoare A; Quest AFG; Díaz-Elizondo J; Pérez-Donoso JM; Bravo D
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612423
[TBL] [Abstract] [Full Text] [Related]
2. Obesity and head and neck cancer risk: a mendelian randomization study.
Gui L; He X; Tang L; Yao J; Pi J
BMC Med Genomics; 2023 Aug; 16(1):200. PubMed ID: 37620971
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Profiling of Aggressive Thyroid cancer in Association With its Clinicopathological Characteristics.
Kim JH; Jeong JY; Seo AN; Park NJ; Kim M; Park JY
In Vivo; 2022; 36(1):111-120. PubMed ID: 34972706
[TBL] [Abstract] [Full Text] [Related]
4. Severe anaphylaxis caused by intravenous anti-cancer drugs.
Horita N; Miyagi E; Mizushima T; Hagihara M; Hata C; Hattori Y; Hayashi N; Irie K; Ishikawa H; Kawabata Y; Kitani Y; Kobayashi N; Kobayashi N; Kurita Y; Miyake Y; Miyake K; Oguri S; Ota I; Shimizu A; Takeuchi M; Yamada A; Yamamoto K; Yukawa N; Masuda M; Oridate N; Ichikawa Y; Kaneko T
Cancer Med; 2021 Oct; 10(20):7174-7183. PubMed ID: 34505396
[TBL] [Abstract] [Full Text] [Related]
5. Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance.
Gao H; Bai P; Xiao L; Shen M; Yu Q; Lei Y; Huang W; Lin X; Zheng X; Wei T; Jiang Y; Ye F; Bu H
J Biol Chem; 2020 Jul; 295(31):10726-10740. PubMed ID: 32532820
[TBL] [Abstract] [Full Text] [Related]
6. Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.
Ibrahimpasic T; Ghossein R; Shah JP; Ganly I
Thyroid; 2019 Mar; 29(3):311-321. PubMed ID: 30747050
[TBL] [Abstract] [Full Text] [Related]
7. Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence.
Bao X; Kong X; Yang C; Wu H; Ma W; Wang R
Medicine (Baltimore); 2018 Jan; 97(4):e9636. PubMed ID: 29369179
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid cancer: Identification of
Ibrahimpasic T; Xu B; Landa I; Dogan S; Middha S; Seshan V; Deraje S; Carlson DL; Migliacci J; Knauf JA; Untch B; Berger MF; Morris L; Tuttle RM; Chan T; Fagin JA; Ghossein R; Ganly I
Clin Cancer Res; 2017 Oct; 23(19):5970-5980. PubMed ID: 28634282
[No Abstract] [Full Text] [Related]
9. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.
Chang PY; Peng SF; Lee CY; Lu CC; Tsai SC; Shieh TM; Wu TS; Tu MG; Chen MY; Yang JS
Int J Oncol; 2013 Oct; 43(4):1141-50. PubMed ID: 23917396
[TBL] [Abstract] [Full Text] [Related]
10. Oral Kaposi's sarcoma: a review and update.
Fatahzadeh M; Schwartz RA
Int J Dermatol; 2013 Jun; 52(6):666-72. PubMed ID: 23679875
[TBL] [Abstract] [Full Text] [Related]
11. Clinical, histological and immunohistochemical findings in oral Kaposi's sarcoma in a series of Mexican AIDS patients. Comparative study.
Ramírez-Amador V; Martínez-Mata G; González-Ramírez I; Anaya-Saavedra G; de Almeida OP
J Oral Pathol Med; 2009 Apr; 38(4):328-33. PubMed ID: 19175711
[TBL] [Abstract] [Full Text] [Related]
12. The burden of oral malignancies in Zimbabwe 1988 to 1997: a population based study.
Marimo C; Hille JJ
Cent Afr J Med; 2006; 52(5-6):51-5. PubMed ID: 18254455
[TBL] [Abstract] [Full Text] [Related]
13. Epidemiology of oral Kaposi's sarcoma in Zimbabwe 1988-1997: a population-based study.
Marimo C
Cent Afr J Med; 2008; 54(1-4):15-9. PubMed ID: 21644423
[TBL] [Abstract] [Full Text] [Related]
14. Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association.
Mwakigonja AR; Pak F; Pyakurel P; Mosha IJ; Urassa WK; Kaaya EE; Biberfeld P
Oncol Rep; 2007 Jun; 17(6):1291-9. PubMed ID: 17487381
[TBL] [Abstract] [Full Text] [Related]
15. Management of oral lesions in HIV-positive patients.
Baccaglini L; Atkinson JC; Patton LL; Glick M; Ficarra G; Peterson DE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S50.e1-23. PubMed ID: 17379155
[TBL] [Abstract] [Full Text] [Related]
16. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
[TBL] [Abstract] [Full Text] [Related]
17. Management of oral Kaposi's sarcoma and a proposal for clinical staging.
Epstein JB
Oral Dis; 1997 May; 3 Suppl 1():S124-8. PubMed ID: 9456673
[TBL] [Abstract] [Full Text] [Related]
